FiercePharma20h
Astellas takes $760M charge, reveals slowdown for eye drug Izervay after regulatory stumbles
Navigating regulatory hurdles in the U.S. and Europe, plus fierce competition from rival Apellis, Astellas’ geographic ...
An EU fund to help troops move quickly is too small and poorly managed, auditors say
Auditors say a European Union fund meant to help speed the deployment of troops and military equipment around the 27-nation ...